Mangoceuticals, Inc. Common Stock (NASDAQ: MGRX) last traded at $0.422, up 9.41% on the session. The quote above updates while this page is open; the figures below are drawn from Mangoceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Mangoceuticals, Inc. Common Stock trades on NASDAQ under the ticker MGRX. Its market capitalisation is $9.10 million.
Valuation measures for Mangoceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.10M |
|---|---|
| Enterprise value | $10.52M |
| Price / sales | 28.87 |
| Price / book | 0.73 |
| Beta | 1.44 |
Trailing-twelve-month figures tagged in Mangoceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $315.2K |
|---|---|
| Net income (TTM) | -$15.10M |
| EPS (TTM) | -$0.790 |
| Gross margin | 54.43% |
| Operating margin | -3916.81% |
| Return on equity | -120.58% |
| Cash | $228.7K |
Range and volume for MGRX over the past 52 weeks.
| 52-week high | $2.75 |
|---|---|
| 52-week low | $0.162 |
| Volume | 936.7K |
| Average volume | 13.58M |
| Previous close | $0.386 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.